PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 156 filers reported holding PRECIGEN INC in Q2 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,979 | -28.7% | 5,619 | -42.3% | 0.00% | – |
| Q2 2023 | $11,194 | +27885.0% | 9,734 | -73.9% | 0.00% | -100.0% |
| Q1 2023 | $40 | -36.5% | 37,277 | -10.5% | 0.00% | -66.7% |
| Q4 2022 | $63 | -99.9% | 41,640 | +53.7% | 0.00% | +200.0% |
| Q3 2022 | $57,000 | +62.9% | 27,090 | +4.9% | 0.00% | 0.0% |
| Q2 2022 | $35,000 | -36.4% | 25,828 | -1.3% | 0.00% | 0.0% |
| Q1 2022 | $55,000 | 0.0% | 26,176 | +76.3% | 0.00% | 0.0% |
| Q4 2021 | $55,000 | -47.6% | 14,845 | -29.5% | 0.00% | -66.7% |
| Q3 2021 | $105,000 | +94.4% | 21,055 | +151.3% | 0.00% | +200.0% |
| Q2 2021 | $54,000 | -12.9% | 8,377 | -6.3% | 0.00% | 0.0% |
| Q1 2021 | $62,000 | +121.4% | 8,945 | +222.0% | 0.00% | 0.0% |
| Q4 2020 | $28,000 | -59.4% | 2,778 | -85.9% | 0.00% | 0.0% |
| Q3 2020 | $69,000 | +1.5% | 19,698 | +44.5% | 0.00% | -66.7% |
| Q2 2020 | $68,000 | – | 13,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |